Changes
Jump to navigation
Jump to search
→Recently Added Core Papers
tags={},
filename={Lessig (2001) - The Future Of Ideas.pdf}
}
Likewise, Kiley (1992)'s article in Science appears to coin the term 'thicket'. It too doesn't merit a write-up:
@article{kiley1992patents,
title={Patents on random complementary DNA fragments?},
author={Kiley, Thomas D},
journal={Science},
volume={257},
number={5072},
pages={915--918},
year={1992},
publisher={American Association for the Advancement of Science},
abstract={The proposal by the National Institutes of Health (NIH) to patent products resulting merely from sequencing the human genome is a mistake: at worst, it is wrong in patent law; at best, it relies on deficiencies in law concerning what is "useful" as a requirement for patents. The proposal is symptomatic of a problem besieging biotechnology-attempts to control the raw material of scientific experimentation before research has determined the practical value of such material-that needs curing on many fronts. Corrective measures are proposed for adoption by the Executive branch, the Congress, and the courts.},
discipline={Law},
research_type={Discussion},
industry={Genetics},
thicket_stance={Pro},
thicket_stance_extract={Because every step along the way draws another patent application, the path towardp ublicp ossessiono f realb enefit is increasinglyo bscuredb y dense thicketso f intersecting, overlapping, and cross-blocking patents.},
thicket_def={#B, #C1, Dubious Patents, Overlapping Patents, Cummulative Invention, Unspecified Blocking Mechanism},
thicket_def_extract={Today, patents are avidly pursued all along the lengthy road from the most basic science throught o the marketplacef or pharmaceuticals. Because every step along the way draws another patent application, the path towardp ublicp ossessiono f realb enefit is increasinglyo bscuredb y dense thicketso f intersecting, overlapping, and cross-blocking patents. Those operating at the beginnings of the road are most insistent on their right to nail down leverage that will remain formidabled espitem arketplacer ejectiono f the uses to which they say their inventions may be put. The frank aim of these early stagew orkersis to control ultimatea pplications discovered by others. The system is abused if those who would benefit in this way from the later labors of others can posit patents on the most strained utilities imaginable. Typical is the suggestion by NIH that organ differentiation( 18) is sufficient utility for a patent reaching to dominate the later discovery by others of a life-saving application for a cDNA!},
tags={First Thicket!},
filename={Kiley (1992) - Patents On Random Complementary Dna Fragments.pdf}
}
